Stock AVTX AVALO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Avalo Therapeutics, Inc.

Equities

AVTX

US05338F3064

Delayed Nasdaq
Other stock markets
 01:07:09 2024-06-04 pm EDT 		5-day change 1st Jan Change
11.21 USD -2.10% Intraday chart for Avalo Therapeutics, Inc. -2.61% +23.19%
May. 13 Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 17 North American Morning Briefing : Stock Futures -2- DJ
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AVALO THERAPEUTICS, INC. Stock Avalo Therapeutics, Inc.
 11.84M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 56.65B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.44B
LONZA GROUP AG Stock Lonza Group AG
 39.03B
CELLTRION, INC. Stock Celltrion, Inc.
 26.86B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.75B
  1. Stock Market
  2. Equities
  3. AVTX Stock
  4. Charts Avalo Therapeutics, Inc.
  5. Sector Chart